Submitted by Anonymous (not verified) on 8 December 2025 - 15:53
Human medicines European public assessment report (EPAR): Yescarta, axicabtagene ciloleucel, Date of authorisation: 23/08/2018, Revision: 21, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Yescarta, axicabtagene ciloleucel, Date of authorisation: 23/08/2018, Revision: 21, Status: Authorised